보고서 요약(국문)

개요
글로벌 생물정보학 서비스 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
"생물정보학 서비스" 범주에는 유전체학 및 기타 오믹스 분야를 포함한 다양한 계산 및 분석 서비스가 포함되며, 생물학적 데이터의 처리, 분석 및 해석을 목표로 합니다. 다양한 고처리량 기술로 생성되는 방대한 양의 생물학적 데이터를 이해하기 위해 이러한 서비스는 생명 과학 및 생의학 분야의 연구원, 과학자 및 기관에 필수적입니다.
DNA 서열, 유전자 주석 및 게놈의 구조적 차이 연구는 모두 유전체 데이터 분석에 포함됩니다. 유전자, 조절 요소 및 돌연변이를 찾는 것은 흔히 수행되는 작업입니다. 유전자 발현 수준, 대체 스플라이싱 및 비코딩 RNA 발현을 조사하기 위한 RNA-Seq 데이터 분석 또한 생물정보학 서비스에 자주 포함됩니다. 단백질 및 대사체 데이터는 단백질체학 및 대사체학 연구의 일환으로 분석되며, 이를 통해 생물학적 기능과 경로를 밝힐 수 있습니다.
시장 동향: 성장 요인
연구 활동 증가
데이터 분석은 단일 세포 연구의 핵심 요소이지만, 연구 현장에 생물정보학 전문가를 상시 배치하는 것이 항상 가능한 것은 아닙니다. 연구자들은 생물정보학 전문가를 채용하거나 기존 팀원을 재교육하는 데 필요한 데이터가 부족한 등의 어려움에 직면합니다. 시장 참여자들은 생물정보학 서비스를 제공하며 시장 성장을 주도하고 있습니다.
예를 들어, 2022년 1월, 돌로마이트 바이오(Dolomite Bio)는 단일 세포 연구용 RNAdia 키트를 출시했습니다. 초기 비용 부담을 줄여 예측을 간소화하고 단일 세포 RNA 시퀀싱을 간편하게 수행할 수 있도록 설계된 이 키트와 함께, 돌로마이트 바이오는 시약처럼 구매할 수 있는 생물정보학 서비스를 선보였습니다.

2022년 10월, 미국에 기반을 둔 두 스타트업 기업인 템푸스 랩스(Tempus Labs)와 벡터빌더 바이오테크놀로지(VectorBuilder Biotechnology)는 정밀 의학 개발을 위해 2억 7,500만 달러를 투자 유치했습니다. 이들 기업은 질병의 진행 과정을 추적하고 임상 시험에 환자를 모집하기 위해 임상 파이프라인 분석에 인공지능(AI) 알고리즘을 광범위하게 활용하고 있습니다.
2022년 4월, 생물학적 물질 관리 및 표준화 분야의 세계적인 선도 기관인 ATCC는 생물정보학 솔루션 제공업체로 잘 알려진 QIAGEN과 인간 및 동물 세포주와 생물학적 물질 컬렉션의 시퀀싱 정보를 공유하기로 합의했습니다.
QIAGEN의 생물정보학 부문인 QIAGEN Digital Insights는 생명공학 및 제약 산업을 위한 고부가가치 디지털 생물학 콘텐츠를 제작 및 제공하기 위해 이 정보를 기반으로 데이터베이스를 구축할 예정입니다. 이를 통해 검증된 생물학적 데이터 세트를 활용하여 새로운 질병 경로를 밝히고 새로운 치료 표적을 발견할 수 있게 됩니다.
데이터 보안 및 개인정보 보호 문제
유전체 및 의료 데이터에는 매우 민감하고 개인적인 정보가 포함될 수 있습니다. 생물정보학 서비스 도입은 개인정보 보호 및 데이터 유출에 대한 우려로 인해 저해될 수 있습니다. 중요한 데이터 보호법(예: GDPR, 일반 데이터 보호 규정)을 준수하는 것은 어렵고 비용이 많이 들 수 있습니다.
세분화 분석
글로벌 생물정보학 서비스 시장은 제품 유형, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
시퀀싱 서비스 부문은 시장 점유율의 약 45.5%를 차지했습니다.
DNA 또는 RNA 분자에서 뉴클레오티드(A, C, G, T)의 정확한 위치를 파악하는 과정을 시퀀싱이라고 합니다. 생물학, 유전학, 유전체학 및 기타 분야의 수많은 응용 분야가 이 메커니즘에 의존합니다.
일루미나(Illumina)에서 제공하는 차세대 시퀀싱(NGS) 서비스에는 빠르고 우수한 품질의 전장 유전체 시퀀싱 서비스가 포함됩니다. 연구실에 다양한 시퀀싱 도구와 NGS 관련 지식이 부족한 경우, 유전체 시퀀싱 프로젝트를 아웃소싱하는 것을 고려해 볼 수 있습니다.

사용자는 빠른 처리 시간, 고성능 장비, 다양한 라이브러리 준비 옵션, 그리고 생물정보학 기능을 활용하여 시퀀싱 서비스를 이용할 수 있습니다. 폭넓은 과학적 지식과 최고 수준의 고객 서비스를 제공하는 Genetic Energy를 경험해 보세요.
또한 Biosearch Technologies는 시퀀싱을 통한 유전자형 분석, 표적 유전자형 분석, 메타게놈 시퀀싱, 미생물 시퀀싱, 전체 게놈 시퀀싱, 그리고 Sanger 시퀀싱 서비스를 제공합니다.
지역 분석
북미는 시장 점유율의 약 41.2%를 차지했습니다.
북미는 글로벌 생물정보학 서비스 시장에서 지배적인 위치를 차지하고 있으며, 활발한 시장 참여자들이 이 지역의 성장을 주도하고 있습니다. 예를 들어, 유전체 기술 분야의 선두 기업인 애질런트 테크놀로지스(Agilent Technologies Inc.)는 2022년 6월, NVIDIA Clara Parabricks의 고급 유전체 분석 기능, Amazon Web Services(AWS) Graviton2 프로세서, 그리고 NVIDIA T4G Tensor Core GPU가 탑재된 Amazon Elastic Compute Cloud(Amazon EC2) G5g 인스턴스를 사용할 것이라고 발표했습니다.
또한, DNA 시퀀싱 및 어레이 기반 기술 분야의 글로벌 리더인 일루미나(Illumina Inc.)와 유전자 검사 및 정밀 의학 분야의 선두 기업인 마이리아드 제네틱스(Myriad Genetics Inc.)는 2023년 3월, 미국 내 종양학 상동 재조합 결핍(HRD) 검사에 대한 접근성과 이용 가능성을 높이기 위해 전략적 파트너십을 확대했습니다. 주로 연구 목적으로 개발된 일루미나 트루사이트 온콜로지 500 HRD(TSO 500 HRD) 검사가 이번 계약에 따라 미국에서 이용 가능하게 되었습니다.

강화된 협력을 통해 제약 부문을 위한 특별한 동반 진단(CDx) 제휴가 구축되어 유전자 기반 표적 치료제에 대한 임상 연구가 더욱 활발해질 것입니다. 해당 제품은 현재 구매 가능하며 미국으로 배송 준비가 완료되었습니다. 배포용 키트는 Myriad에서, 중앙 집중식 실험실 서비스는 Illumina에서 각각 제공합니다.
COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 글로벌 생물정보학 서비스 시장에 전례 없는 어려움을 초래했습니다. SARS-CoV-2 바이러스의 유전적 차이를 이해해야 할 필요성 때문에 팬데믹으로 인해 유전체 시퀀싱 및 분석에 대한 수요가 증가했습니다. 그 결과, 유전체학 및 생물정보학 서비스를 제공하는 기업들은 사업이 급증했습니다.

반면, 공급망 중단과 실험실 폐쇄로 인해 수많은 연구 프로젝트가 연기되거나 일시적으로 중단되었습니다. 결과적으로 생물정보학 서비스에 대한 수요가 감소했습니다.

제품 유형별
• 시퀀싱 서비스
• 데이터 분석 서비스
• 유전자 발현 분석
• 신약 개발 서비스
• 데이터베이스 관리
• 기타
응용 분야별
• 대사체학
• 단백체학
• 전사체학
• 화학정보학 및 신약 설계
• 유전체학
• 기타
최종 사용자별
• 병원 및 클리닉
• 제약 및 생명공학 기업
• 학술 기관 및 연구 센터
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
주요 글로벌 시장 참여 기업으로는 Illumina, Inc., PerkinElmer Inc., Premier Biosoft, QIAGEN N.V., Strand Life 등이 있습니다. 주요 기업으로는 Sciences, Inc., Thermo Fisher Scientific, Agilent Technologies, Inc., BGI Group, Biomatters Geneious, Biomax Informatics AG 등이 있습니다.

주요 개발 사항
• 2021년 1월, Illumina, Inc.는 Illumina Connected Analytics(ICA)를 출시하여 유전체 데이터의 병목 현상을 촉매제로 전환했습니다. 이 혁신적이고 통합된 생물정보학 솔루션이 제공하는 포괄적이고 안전한 클라우드 기반 데이터 플랫폼을 통해 사용자는 방대한 양의 멀티오믹스 데이터를 안전하고 유연하며 보안이 강화된 환경에서 관리, 분석 및 연구할 수 있습니다.
보고서 구매 이유

• 제품 유형, 애플리케이션, 최종 사용자 및 지역별 글로벌 생물정보학 서비스 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별하기 위해

• 모든 세그먼트를 포함한 생물정보학 서비스 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 포함된 PDF 보고서

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.
글로벌 생물정보학 서비스 시장 보고서는 약 61개의 표, 63개의 그림, 그리고 186페이지 분량입니다.
2023년 주요 고객층
• 제조업체/구매자
• 산업 투자자/투자은행
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The Global Bioinformatics Services Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
A variety of computational and analytical services, including genomics and other omics disciplines, are included in the category of "bioinformatics services" and are aimed at processing, analyzing, and interpreting biological data. To make sense of the enormous volume of biological data produced by various high-throughput techniques, these services are crucial for researchers, scientists, and organizations working in the life sciences and biomedical sectors.
The study of DNA sequences, gene annotations, and structural differences in genomes are all included in genomic data analysis. Finding genes, regulatory components, and mutations is a frequent endeavor. Analysis of RNA-Seq data for the purposes of examining gene expression levels, alternative splicing, and non-coding RNA expression is frequently included in bioinformatics services. Protein and metabolite data are analyzed as part of proteomics and metabolomics research, which can shed light on biological functions and pathways.
Market Dynamics: Drivers
Increasing Research Activities
Data analysis is a crucial component of single-cell research although having access to bioinformatic expertise on-site is not always feasible. Researchers encounter challenges including having insufficient data to support hiring a bioinformatician on staff or retraining an already-existing team member. The market players are offering bioinformatics services that drive the market.
For instance, in January 2022, in light of the recently released RNAdia kit for single-cell research from Dolomite Bio. With upfront expenses making forecasting simple and single-cell RNA-sequencing hassle-free, Dolomite Bio introduced a bioinformatics service that can be purchased alongside the kit much like reagents.
In October 2022, Tempus Labs and VectorBuilder Biotechnology, two startup businesses based in the United States, raised USD 275 million for the development of precision medicine. To track a disease's progression and enroll patients in clinical trials, these businesses are widely utilizing Artificial Intelligence (AI) algorithms in clinical pipeline analysis.
In April 2022, the world's leading organization for the management and standardization of biological materials, ATCC, agreed with QIAGEN, a well-known provider of bioinformatics solutions, to share sequencing information from its collection of human and animal cell lines and biological materials with them.
In order to create and deliver high-value digital biology content for the biotechnology and pharmaceutical industries, QIAGEN Digital Insights, the bioinformatics division of QIAGEN, will create a database from this information. This will allow for the use of authenticated biological data sets to uncover new disease pathways and discover novel therapeutic targets.
Data Security and Privacy Concerns
Highly sensitive and private information can be found in genomic and medical data. The uptake of bioinformatics services may be hampered by worries about privacy and data breaches. Although important, observing data protection laws like the GDPR (General Data Protection Regulation) can be difficult and expensive.
Segment Analysis
The global bioinformatics services market is segmented based on product type, application, end-user and region.
The sequencing services segment accounted for approximately 45.5% of the market share
The process of figuring out the precise placement of nucleotides (A, C, G, and T) in a DNA or RNA molecule is known as sequencing. Numerous applications in biology, genetics, genomics, and other disciplines depend on this mechanism.
Accessible next-generation sequencing (NGS) services from Illumina include whole-genome sequencing services that are quick and of excellent quality. The user might want to think about outsourcing their genome sequencing projects if their lab doesn't already have access to a variety of sequencing tools and NGS knowledge.
User can take advantage of quick turnaround times, high-throughput equipment, library prep choices, and bioinformatics capabilities with their sequencing services. With their broad scientific knowledge and first-rate customer service, experience Genetic Energy.
In addition, Biosearch Technologies offers genotyping by sequencing, targeted genotyping by sequencing, metagenomics sequencing, microbial sequencing and whole genome sequencing, and sanger sequencing services.
Geographical Analysis
North America accounted for approximately 41.2% of the market share
North America has been a dominant force in the global bioinformatics services market. The active market players are driving the region. For instance, in June 2022, Agilent Technologies Inc., a leader in the field of genomics technology, reported that it will use Amazon Elastic Compute Cloud (Amazon EC2) G5g instances with NVIDIA Clara Parabricks' advanced genomics analysis capabilities, Amazon Web Services (AWS) Graviton2 processors, and Amazon Elastic Compute Cloud (Amazon EC2) G5g instances with NVIDIA T4G Tensor Core GPUs.
In March 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies, and Myriad Genetics Inc., a leader in genetic testing and precision medicine, expanded a strategic partnership to increase access to and availability of oncology homologous recombination deficiency (HRD) testing in the United States. Illumina TruSight Oncology 500 HRD (TSO 500 HRD), a test intended primarily for research purposes, is now accessible in the US as per the agreement.
The strengthened collaboration also creates a special companion diagnostic (CDx) alliance for the pharmaceutical sector, enabling greater clinical study for gene-based, targeted medicines. The item is now available for purchase and is prepared for delivery to the US. Distributable kits and centralized laboratory services are provided by Myriad and Illumina, respectively.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global bioinformatics services market. Due to the necessity to comprehend the genetic differences of the SARS-CoV-2 virus, the pandemic increased the demand for genomic sequencing and analysis. As a result, businesses that provide services in genomics and bioinformatics saw a surge in business.
On the other side, due to supply chain interruptions and laboratory closures, numerous research initiatives had to be postponed or temporarily stopped. Consequently, the demand for bioinformatics services was impacted.
By Product Type
• Sequencing Services
• Data Analysis Services
• Gene Expression
• Drug Discovery Services
• Data Base Management
• Others
By Application
• Metabolomics
• Proteomics
• Transcriptomics
• Chemoinformatics & Drug Design
• Genomics
• Others
By End-User
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Academic Institutes & Research Centers
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Illumina, Inc., PerkinElmer Inc., Premier Biosoft, QIAGEN N.V., Strand Life Sciences, Inc., Thermo Fisher Scientific, Agilent Technologies, Inc., BGI Group, Biomatters Geneious, and Biomax Informatics AG.
Key Developments
• In January 2021, Illumina, Inc. is turning genomic data bottlenecks into catalysts with the introduction of Illumina Connected Analytics (ICA). The comprehensive, private, cloud-based data platform offered by this innovative and integrated bioinformatics solution enables users to manage, analyze, and study huge volumes of multi-omic data in a safe, adaptable, and secure setting.
Why Purchase the Report?
• To visualize the global bioinformatics services market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of bioinformatics services market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global bioinformatics services market report would provide approximately 61 tables, 63 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Research Activities
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Data Security and Privacy Concerns
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Sequencing Services*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Data Analysis Services
7.4. Gene Expression
7.5. Drug Discovery Services
7.6. Data Base Management
7.7. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Metabolomics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Proteomics
8.4. Transcriptomics
8.5. Chemoinformatics & Drug Design
8.6. Genomics
8.7. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Pharmaceutical & Biotechnology Companies
9.4. Academic Institutes & Research Centers
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Illumina, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. PerkinElmer Inc.
12.3. Premier Biosoft
12.4. QIAGEN N.V.
12.5. Strand Life Sciences, Inc.
12.6. Thermo Fisher Scientific
12.7. Agilent Technologies, Inc.
12.8. BGI Group
12.9. Biomatters Geneious
12.10. Biomax Informatics AG
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Illumina, Inc., 4.	Key Developments, PerkinElmer Inc., Premier Biosoft, QIAGEN N.V., Strand Life Sciences, Inc., Thermo Fisher Scientific, Agilent Technologies, Inc., BGI Group, Biomatters Geneious, Biomax Informatics AG

표 목록 (Tables)

List of Tables

Table 1 Global Bioinformatics Services Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Bioinformatics Services Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Bioinformatics Services Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Bioinformatics Services Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Bioinformatics Services Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Bioinformatics Services Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Bioinformatics Services Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Bioinformatics Services Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Bioinformatics Services Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Bioinformatics Services Market Value, By End-User, 2022-2031 (US$ Million)

Table 11 Global Bioinformatics Services Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Bioinformatics Services Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Bioinformatics Services Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Bioinformatics Services Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Bioinformatics Services Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Bioinformatics Services Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Bioinformatics Services Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Bioinformatics Services Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Bioinformatics Services Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 South America Bioinformatics Services Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Bioinformatics Services Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Bioinformatics Services Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Bioinformatics Services Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 Europe Bioinformatics Services Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Bioinformatics Services Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Bioinformatics Services Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Bioinformatics Services Market Value, By End-User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Bioinformatics Services Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Bioinformatics Services Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Bioinformatics Services Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Bioinformatics Services Market Value, By End-User, 2022-2031 (US$ Million)

Table 32 Illumina, Inc.: Overview

Table 33 Illumina, Inc.: Product Portfolio

Table 34 Illumina, Inc.: Key Developments

Table 35 PerkinElmer Inc.: Overview

Table 36 PerkinElmer Inc.: Product Portfolio

Table 37 PerkinElmer Inc.: Key Developments

Table 38 Premier Biosoft: Overview

Table 39 Premier Biosoft: Product Portfolio

Table 40 Premier Biosoft: Key Developments

Table 41 QIAGEN N.V.: Overview

Table 42 QIAGEN N.V.: Product Portfolio

Table 43 QIAGEN N.V.: Key Developments

Table 44 Strand Life Sciences, Inc.: Overview

Table 45 Strand Life Sciences, Inc.: Product Portfolio

Table 46 Strand Life Sciences, Inc.: Key Developments

Table 47 Thermo Fisher Scientific: Overview

Table 48 Thermo Fisher Scientific: Product Portfolio

Table 49 Thermo Fisher Scientific: Key Developments

Table 50 Agilent Technologies, Inc.: Overview

Table 51 Agilent Technologies, Inc.: Product Portfolio

Table 52 Agilent Technologies, Inc.: Key Developments

Table 53 BGI Group: Overview

Table 54 BGI Group: Product Portfolio

Table 55 BGI Group: Key Developments

Table 56 Biomatters Geneious: Overview

Table 57 Biomatters Geneious: Product Portfolio

Table 58 Biomatters Geneious: Key Developments

Table 59 Biomax Informatics AG: Overview

Table 60 Biomax Informatics AG: Product Portfolio

Table 61 Biomax Informatics AG: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 2 Global Bioinformatics Services Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Bioinformatics Services Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Bioinformatics Services Market Share, By End-User, 2022 & 2031 (%)

Figure 5 Global Bioinformatics Services Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Bioinformatics Services Market Y-o-Y Growth, By Product Type, 2022-2031(%)

Figure 7 Sequencing Services Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 8 Data Analysis Services Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 9 Gene Expression Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 10 Drug Discovery Services Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 11 Data Base Management Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 12 Others Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 13 Global Bioinformatics Services Market Y-o-Y Growth, By Application, 2022-2031(%)

Figure 14 Metabolomics Application in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 15 Proteomics Application in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 16 Transcriptomics Application in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 17 Chemoinformatics & Drug Design Application in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 18 Genomics Application in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 19 Others Application in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 20 Global Bioinformatics Services Market Y-o-Y Growth, By End-User, 2022-2031(%)

Figure 21 Hospitals & Clinics End-User in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 22 Pharmaceutical & Biotechnology Companies End-User in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 23 Academic Institutes & Research Centers End-User in Global Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 24 Global Bioinformatics Services Market Y-o-Y Growth, By Region, 2022-2031(%)

Figure 25 North America Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 26 Asia-Pacific Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 27 Europe Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 28 South America Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 29 Middle East and Africa Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 30 North America Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 31 North America Bioinformatics Services Market Share, By Product Type, 2022 & 2031 (%)

Figure 32 North America Bioinformatics Services Market Share, By Application, 2022 & 2031 (%)

Figure 33 North America Bioinformatics Services Market Share, By End-User, 2022 & 2031 (%)

Figure 34 North America Bioinformatics Services Market Share, By Country, 2022 & 2031 (%)

Figure 35 South America Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 36 South America Bioinformatics Services Market Share, By Product Type, 2022 & 2031 (%)

Figure 37 South America Bioinformatics Services Market Share, By Application, 2022 & 2031 (%)

Figure 38 South America Bioinformatics Services Market Share, By End-User, 2022 & 2031 (%)

Figure 39 South America Bioinformatics Services Market Share, By Country, 2022 & 2031 (%)

Figure 40 Europe Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 41 Europe Bioinformatics Services Market Share, By Product Type, 2022 & 2031 (%)

Figure 42 Europe Bioinformatics Services Market Share, By Application, 2022 & 2031 (%)

Figure 43 Europe Bioinformatics Services Market Share, By End-User, 2022 & 2031 (%)

Figure 44 Europe Bioinformatics Services Market Share, By Country, 2022 & 2031 (%)

Figure 45 Asia-Pacific Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 46 Asia-Pacific Bioinformatics Services Market Share, By Product Type, 2022 & 2031 (%)

Figure 47 Asia-Pacific Bioinformatics Services Market Share, By Application, 2022 & 2031 (%)

Figure 48 Asia-Pacific Bioinformatics Services Market Share, By End-User, 2022 & 2031 (%)

Figure 49 Asia-Pacific Bioinformatics Services Market Share, By Country, 2022 & 2031 (%)

Figure 50 Middle East & Africa Bioinformatics Services Market Value, 2022-2031 (US$ Million)

Figure 51 Middle East & Africa Bioinformatics Services Market Share, By Product Type, 2022 & 2031 (%)

Figure 52 Middle East & Africa Bioinformatics Services Market Share, By Application, 2022 & 2031 (%)

Figure 53 Middle East & Africa Bioinformatics Services Market Share, By End-User, 2022 & 2031 (%)

Figure 54 Illumina, Inc.: Financials

Figure 55 PerkinElmer Inc.: Financials

Figure 56 Premier Biosoft: Financials

Figure 57 QIAGEN N.V.: Financials

Figure 58 Strand Life Sciences, Inc.: Financials

Figure 59 Thermo Fisher Scientific: Financials

Figure 60 Agilent Technologies, Inc.: Financials

Figure 61 BGI Group: Financials

Figure 62 Biomatters Geneious: Financials

Figure 63 Biomax Informatics AG: Financials

글로벌 생물정보학 서비스 시장 – 2023-2030

Global Bioinformatics Services Market - 2023-2030